Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 18CNS 8Genitourinary 6Gastrointestinal 6Other solid neoplasm 3Dermatologic 3Thoracic 2Gynecologic 2Lymphoid 1Head & Neck 1

Conditions

Lymphoma 725Lymphoma, Non-Hodgkin 657Precursor Cell Lymphoblastic Leukemia-Lymphoma 583Leukemia, Lymphocytic, Chronic, B-Cell 555Lymphoma, Large B-Cell, Diffuse 440Lymphoma, Follicular 418Lymphoma, Mantle-Cell 345Burkitt Lymphoma 306Leukemia 303Leukemia, Myeloid, Acute 297Hodgkin Disease 293Lymphoma, B-Cell 280Lymphoma, B-Cell, Marginal Zone 267Recurrence 246Multiple Myeloma 205Neoplasms 199Lymphoma, T-Cell, Cutaneous 171Myelodysplastic Syndromes 170Lymphoma, Large-Cell, Immunoblastic 160Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 159Waldenstrom Macroglobulinemia 146Lymphoma, Large-Cell, Anaplastic 142Mycosis Fungoides 132Sezary Syndrome 119Immunoblastic Lymphadenopathy 108Blast Crisis 92Hematologic Neoplasms 91Lymphoma, T-Cell, Peripheral 86Leukemia, Myelogenous, Chronic, BCR-ABL Positive 86Lymphoma, T-Cell 82

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neurofibrosarcoma × Lymphoid × Clear all
NCT01169584 2016-01-21

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

SillaJen, Inc.

Phase 1 Completed
6 enrolled
CNSGenitourinaryLymphoidSarcoma

Lymphoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Vaccinia, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡